Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
Leukemia & Lymphoma|June 28, 2001
Prognostic implications of p27 and cyclin E protein contents in malignant lymphomasM Erlanson, G LandbergCytometry|July 17, 1998
Flow cytometric quantification of cyclin E in human cell lines and hematopoietic malignanciesM Erlanson, G LandbergCancer Chemotherapy and Pharmacology|January 1, 1992
Relations between the penetration, binding and average concentration of cytostatic drugs in human tumour spheroidsM Erlanson, E Daniel-Szolgay, J CarlssonEuropean Journal of Haematology|February 1, 1994
Chronic lymphocytic leukemia: a retrospective study of 122 casesM Erlanson, B Osterman, H Jonsson, et al.Acta Oncologica (Stockholm, Sweden)|January 1, 1997
Flow cytometric evaluation of proliferating cell nuclear antigen expression in human hematopoietic malignanciesM Erlanson, G Landberg, J Lindh, et al.Hematological Oncology|July 1, 1995
Cell kinetic analysis of non-Hodgkin's lymphomas using in vivo iododeoxyuridine incorporation and flow cytometryM Erlanson, J Lindh, B Zackrisson, et al.European Journal of Haematology|March 21, 1998
Expression of activation markers CD23 and CD69 in B-cell non-Hodgkin's lymphomaM Erlanson, E Grönlund, E Löfvenberg, et al.International Journal of Radiation Oncology, Biology, Physics|May 1, 1991
Planning of radiotherapy for patients with hip prosthesisM Erlanson, L Franzén, R Henriksson, et al.Blood|July 10, 1998
Telomerase activity in Hodgkin's diseaseK F Norrback, G Enblad, M Erlanson, et al.Lakartidningen|February 12, 1998
[Late side-effects are common after treatment of Hodgkin's disease. Muscular atrophy following radiotherapy is a neglected risk]A S Johansson, M Erlanson, P Lenner, et al.Pageof 3